Biochemistry, Genetics and Molecular Biology
DNA Methylation
100%
Methylation
88%
Epigenetics
56%
CpG Island
34%
Promoter Region
31%
Myeloid
29%
Cancer Cell
21%
Gene Expression
17%
Reprogramming
17%
Decitabine
14%
Next Generation Sequencing
13%
Allele
13%
Methylome
12%
DNMT3A
11%
Single Nucleotide Polymorphism
11%
Single-Nucleotide Polymorphism
11%
Immunity
11%
Embryonic Stem Cell
10%
Colon
10%
Isoform
10%
Transcriptome
9%
Reduced Representation Bisulfite Sequencing
9%
Genomics
9%
Non-Coding RNA
9%
Histone Modification
8%
Upregulation
8%
Gene Promoter
8%
Tumor Progression
8%
Bisulfite
8%
Stem Cell
8%
DNA Sequence
7%
Expressed Sequence Tag
7%
MLL3
7%
CD4
7%
Retrotransposon
7%
Epigenetic Modification
7%
Long Non-Coding RNA
7%
High Throughput Sequencing
7%
Regulatory T Cell
6%
Transgenic Mouse
6%
Pyrosequencing
6%
T Cell
6%
Carcinogenesis
6%
5-Methylcytosine
5%
Genetic Marker
5%
Genetics
5%
Epigenomics
5%
Epigenetics
5%
Long Noncoding RNA
5%
Long Interspersed Repeat
5%
Keyphrases
DNA Methylation (DNAm)
38%
Methylation
28%
CpG Island
16%
Chronic Myeloid Leukemia
12%
Myelodysplastic Syndrome
12%
In Cancer
10%
Acute Myeloid Leukemia
9%
Leukemia
9%
Tumor
8%
Promoter Methylation
8%
Tet Methylcytosine Dioxygenase 2
8%
Decitabine
8%
Transcriptional Repression
8%
Hypomethylating Agents
7%
Epigenetic Modification
7%
DNMT3A
7%
Gene Expression
7%
DNA Methylation Pattern
7%
CCAT2
7%
Long Non-coding RNA (LncRNA)
7%
TET2 mutation
7%
Resistance to Immunotherapy
7%
Epigenetic Reprogramming
7%
Bone Morphogenetic protein-7 (BMP-7)
7%
Next-generation Sequencing
7%
Reduced Representation Bisulfite Sequencing
6%
Hypomethylation
6%
Methylation Status
6%
Gene Promoter
5%
Colorectal Cancer
5%
Methylation Changes
5%
Leukemia Cell Lines
5%
Medicine and Dentistry
Methylation
17%
DNA Methylation
15%
Neoplasm
12%
CpG Island
10%
Promoter Region
8%
Malignant Neoplasm
8%
Myelodysplastic Syndrome
7%
Hypomethylating Agent
7%
Decitabine
6%
Xenograft
6%
Acute Myeloid Leukemia
5%
Leukemia
5%
